EU Council and Parliament negotiators reached a provisional "pharma package" deal to modernize medicine rules, speed patient ...
The difference between a job and a career is what you walk away with when it ends. Here's how to evaluate if your role and ...
Clearmind Medicine shares dropped in after-hours trading following the company's announcement of a 1-for-40 reverse stock ...
The US Congress is moving forward with a tougher stance on China through the National Defense Authorization Act (NDAA), even ...
Jacksonville Journal-Courier on MSNOpinion
Commentary: America surrendering its biotech crown — Karen Kerrigan
Commentary: Health and Human Services justified its decision by citing public mistrust in vaccines based on mRNA technology, ...
Pharma companies need to move beyond the “weight loss Olympics” and focus on more durable treatments with fewer side effects, ...
Strong manufacturing base a driving force behind overseas expansion, but industry leaders and analysts say hurdles remain.
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...
Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of ...
Hong Kong has surged back to the top of global IPO rankings for the first time since 2019, fuelled by a record wave of A+H ...
Congress is poised to pass the Biosecure Act after two years of incremental changes that watered down the bill’s curbs on Chinese biotechs ...
15 小时on MSNOpinion
The Fed cut rates. Biotech didn’t notice.
Biotechs are instead spending their time advancing the kind of smart science that will catch the eye of cash-rich ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈